Log In
News

NobleCon19 Webcasts

12/14/2023
Business
0 min read

If you didn’t make it to the LIVE event, or even if you did and want to revisit this memorable conference, here’s your opportunity exclusively on Channelchek.

Panels, Special Presentations, and Analyst Takeaways

Corporate Presentations

NobleCon19 Sponsors

Learn More: Seeking Alpha  |  Privaira  |  AON  |  The Money Channel

Learn More: The Nuvo Group  |  FAU  |  Boca Raton  |  Investor Brand Network  |  SLS
Harter Secrest & Emery  |  Marcum  |  GreenbergTraurig  |  Lowenstein Sandler  |  StoneX
Dickinson Wright

Learn More: CFA Society South Florida  |  Palm Beach Hedge Fund Association 
 Boca Magazine | Delray Magazine | South Florida Stock & Bond Club
Nasdaq | Miami Finance Forum | Nelson Mullins

Share
Related News
‌
Fed’s Preferred Inflation Gauge Stubbornly High at 2.8%, Locking in Higher Rates
4/26/2024
Economy

Fed’s Preferred Inflation Gauge Stubbornly High at 2.8%, Locking in Higher Rates

Inflation in the United States showed alarmingly little signs of cooling in March, according to the latest data on the Federal Reserve’s preferred price gauge released Friday. The stubbornly elevated...
3 min read
‌
Incyte Shells Out $750M for Escient’s Immunology Assets
4/26/2024
Health

Incyte Shells Out $750M for Escient’s Immunology Assets

In a move that further solidifies its position in the inflammatory disease space, Incyte Corporation has agreed to acquire Escient Pharmaceuticals for $750 million. The deal, announced on Tuesday, will...
3 min read
‌
Release – ACCO Brands Corporation Declares Quarterly Dividend
4/26/2024
Consumer

Release – ACCO Brands Corporation Declares Quarterly Dividend

ACCO Brands Corporation (NYSE: ACCO) today announced that its board of directors has declared a quarterly cash dividend of $0.075 per share. The dividend will be paid on June 12,...
2 min read
‌
Release – Ocugen To Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting
4/26/2024
Health

Release – Ocugen To Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will...
6 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In